We are live on ! Find out more
BRM

Boston Research & Management Portfolio holdings

AUM $421M
1-Year Est. Return 16.18%
This Fund
S&P 500
This Quarter Est. Return
+11.83%
1 Year Est. Return
+16.18%
3 Year Est. Return
+48.21%
5 Year Est. Return
+65.09%
10 Year Est. Return
+242.1%
AUM
$240M
AUM Growth
+$30M
Cap. Flow
+$6.46M
Cap. Flow %
2.69%
Top 10 Hldgs %
25.18%
Holding
105
New
5
Increased
27
Reduced
32
Closed
1

Top Buys

Rank Stock Value
1
DIS icon
Walt Disney
DIS
+$2.58M
2
CVS icon
CVS Health
CVS
+$670K
3
GIS icon
General Mills
GIS
+$601K
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$455K
5
LIN icon
Linde
LIN
+$351K

Top Sells

Rank Stock Value
1
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$384K
2
ABT icon
Abbott
ABT
+$224K
3
FAST icon
Fastenal
FAST
+$223K
4
MA icon
Mastercard
MA
+$222K
5
INTC icon
Intel
INTC
+$189K

Sector Composition

Rank Sector Weight
1 Technology 14.55%
2 Industrials 12.87%
3 Healthcare 12.11%
4 Consumer Staples 11.61%
5 Financials 9.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VTI icon
51
Vanguard Morningstar Total Stock Market ETF
VTI
$660B
$1.79M 0.75%
12,380
IAU icon
52
iShares Gold Trust
IAU
$62.9B
$1.51M 0.63%
61,155
+650
+1% +$16.2K
JNJ icon
53
Johnson & Johnson
JNJ
$618B
$1.31M 0.54%
9,355
IBB icon
54
iShares Biotechnology ETF
IBB
$9.34B
$1.28M 0.53%
11,444
+630
+6% +$69.1K
CVX icon
55
Chevron
CVX
$392B
$1.28M 0.53%
10,367
+75
+0.7% +$8.87K
CTAS icon
56
Cintas
CTAS
$81.9B
$1.12M 0.47%
22,120
T icon
57
AT&T
T
$159B
$1.05M 0.44%
44,357
IJH icon
58
iShares Core S&P Mid-Cap ETF
IJH
$122B
$1.05M 0.44%
27,630
+2,265
+9% +$83.6K
GOOG icon
59
Alphabet (Google) Class C
GOOG
$4.36T
$1.01M 0.42%
17,280
VEA icon
60
Vanguard FTSE Developed Markets ETF
VEA
$229B
$953K 0.4%
23,330
JPM icon
61
JPMorgan Chase
JPM
$935B
$896K 0.37%
8,853
SYK icon
62
Stryker
SYK
$125B
$895K 0.37%
4,534
PFE icon
63
Pfizer
PFE
$143B
$856K 0.36%
21,261
VWO icon
64
Vanguard FTSE Emerging Markets ETF
VWO
$121B
$787K 0.33%
18,520
IEZ icon
65
iShares US Oil Equipment & Services ETF
IEZ
$361M
$772K 0.32%
30,590
+10,650
+53% +$262K
OIH icon
66
VanEck Oil Services ETF
OIH
$2.06B
$733K 0.31%
2,130
-159
-7% -$53.6K
DUK icon
67
Duke Energy
DUK
$97.8B
$707K 0.29%
7,859
NEE icon
68
NextEra Energy
NEE
$181B
$690K 0.29%
14,280
AOR icon
69
iShares Core 60/40 Balanced Allocation ETF
AOR
$3.66B
$658K 0.27%
14,727
+5
+0% +$217
BXP icon
70
Boston Properties
BXP
$11.2B
$649K 0.27%
4,850
ORCL icon
71
Oracle
ORCL
$374B
$621K 0.26%
11,564
PAYX icon
72
Paychex
PAYX
$41.6B
$621K 0.26%
7,755
VEU icon
73
Vanguard FTSE All-World ex-US ETF
VEU
$66.6B
$605K 0.25%
12,079
-300
-2% -$14.7K
BA icon
74
Boeing
BA
$171B
$599K 0.25%
1,571
LLY icon
75
Eli Lilly
LLY
$1.02T
$580K 0.24%
4,473
-27
-0.6% -$3.28K

Similar funds

Boston Research & Management's Q1 2019 Portfolio in Review

As of Q1 2019, Boston Research & Management held 105 positions worth $240M, up 14% from $210M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Boston Research & Management's Q1 2019 filing shows 5 new, 27 increased, 32 reduced and 1 closed positions. Its largest new stake was Vanguard Morningstar Growth ETF: 10,230 shares worth $266K. The largest sale was Berkshire Hathaway Class B, an estimated $384K.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Industrials and Healthcare.

  • Boston Research & Management's largest Q1 2019 buy was Vanguard Morningstar Growth ETF: 10,230 shares worth $266K.
  • Boston Research & Management added most to Walt Disney in Q1 2019, an estimated $2.58M increase.
  • Boston Research & Management's biggest Q1 2019 reduction was Berkshire Hathaway Class B, cutting an estimated $384K.
  • Boston Research & Management fully exited Alerian MLP ETF in Q1 2019, selling an estimated $168K.
  • Boston Research & Management's ten largest holdings make up 25% of its $240M portfolio in Q1 2019.
  • Boston Research & Management opened 5 new positions and closed 1 in Q1 2019.
  • Boston Research & Management's portfolio value rose 14% quarter-over-quarter to $240M.

Based on Boston Research & Management's 13F filing for Q1 2019, filed 7 May 2019.